Nalaganje...
Development of anti-HER2-targeted doxorubicin–core-shell chitosan nanoparticles for the treatment of human breast cancer
Purpose: Doxorubicin (DOX) encapsulated O-succinyl chitosan graft Pluronic(®) F127 (OCP) copolymer nanoparticles conjugated with an anti-HER2 monoclonal antibody were developed as targeted drug delivery vehicles for the treatment of HER2-overexpressing breast cancer. Methods: Five percent and 10% (w...
Shranjeno v:
| izdano v: | Int J Nanomedicine |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6557189/ https://ncbi.nlm.nih.gov/pubmed/31239670 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S198552 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|